Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,214.97 +42.82 (+0.52%) Bitcoin USD
61,772.75 +3,350.68 (+5.74%) CMC Crypto 200
1,325.55 +48.58 (+3.81%)
Vir Biotechnology, Inc. (VIR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:02AM EDT. Market open.
| Previous close | 9.18 |
| Open | 10.14 |
| Bid | 7.56 x 200 |
| Ask | 12.87 x 200 |
| Day's range | 10.02 - 10.59 |
| 52-week range | 7.61 - 27.48 |
| Volume | |
| Avg. volume | 1,036,300 |
| Market cap | 1.403B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Thomson Reuters StreetEvents
Q1 2024 Vir Biotechnology Inc Earnings Call
Q1 2024 Vir Biotechnology Inc Earnings Call
- GuruFocus.com
Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Despite a dip in revenue, VIR showcases robust clinical progress and strategic regulatory engagements, underpinned by a strong cash reserve.
- Zacks
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
Vir Biotechnology (VIR) delivered earnings and revenue surprises of 51.52% and 250.82%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.